Your browser doesn't support javascript.
loading
Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study.
Gao, Yue; Zeng, Shaoqing; Xu, Xiaoyan; Li, Huayi; Yao, Shuzhong; Song, Kun; Li, Xiao; Chen, Lingxi; Tang, Junying; Xing, Hui; Yu, Zhiying; Zhang, Qinghua; Zeng, Shue; Yi, Cunjian; Xie, Hongning; Xiong, Xiaoming; Cai, Guangyao; Wang, Zhi; Wu, Yuan; Chi, Jianhua; Jiao, Xiaofei; Qin, Yan; Mao, Xiaogang; Chen, Yu; Jin, Xin; Mo, Qingqing; Chen, Pingbo; Huang, Yi; Shi, Yushuang; Wang, Junmei; Zhou, Yimin; Ding, Shuping; Zhu, Shan; Liu, Xin; Dong, Xiangyi; Cheng, Lin; Zhu, Linlin; Cheng, Huanhuan; Cha, Li; Hao, Yanli; Jin, Chunchun; Zhang, Ludan; Zhou, Peng; Sun, Meng; Xu, Qin; Chen, Kehua; Gao, Zeyan; Zhang, Xu; Ma, Yuanyuan; Liu, Yan.
Affiliation
  • Gao Y; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Zeng S; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Xu X; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Li H; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Yao S; Department of Obstetrics and Gynecology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Song K; Gynecology Oncology Key Laboratory, Qilu Hospital, Shandong University, Jinan City, China.
  • Li X; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Chen L; City University of Hong Kong Shenzhen Research Institute, Shenzhen, China.
  • Tang J; First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Xing H; Department of Obstetrics and Gynecology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
  • Yu Z; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Zhang Q; Department of Obstetrics and Gynecology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zeng S; Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Yi C; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
  • Xie H; Department of Ultrasonic Medicine, Fetal Medicine Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Xiong X; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Cai G; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Wang Z; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Wu Y; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Chi J; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Jiao X; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Qin Y; First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Mao X; Department of Obstetrics and Gynecology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
  • Chen Y; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Jin X; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Mo Q; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Chen P; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Huang Y; Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Shi Y; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
  • Wang J; Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Zhou Y; Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Ding S; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Zhu S; National Clinical Research Center for Obstetrics and Gynaecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education) and Department of Gynaecology and Obstetrics, Tongji Hospital, Wuhan, China.
  • Liu X; Gynecology Oncology Key Laboratory, Qilu Hospital, Shandong University, Jinan City, China; Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Dong X; Gynecology Oncology Key Laboratory, Qilu Hospital, Shandong University, Jinan City, China.
  • Cheng L; Gynecology Oncology Key Laboratory, Qilu Hospital, Shandong University, Jinan City, China.
  • Zhu L; Gynecology Oncology Key Laboratory, Qilu Hospital, Shandong University, Jinan City, China.
  • Cheng H; Gynecology Oncology Key Laboratory, Qilu Hospital, Shandong University, Jinan City, China.
  • Cha L; Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hao Y; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Jin C; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Zhang L; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Zhou P; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Sun M; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Xu Q; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Chen K; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Gao Z; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Zhang X; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Ma Y; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
  • Liu Y; Department of Gynecology, The Second People's Hospital of Shenzhen, Shenzhen, China.
Lancet Digit Health ; 4(3): e179-e187, 2022 03.
Article in En | MEDLINE | ID: mdl-35216752
ABSTRACT

BACKGROUND:

Ultrasound is a critical non-invasive test for preoperative diagnosis of ovarian cancer. Deep learning is making advances in image-recognition tasks; therefore, we aimed to develop a deep convolutional neural network (DCNN) model that automates evaluation of ultrasound images and to facilitate a more accurate diagnosis of ovarian cancer than existing methods.

METHODS:

In this retrospective, multicentre, diagnostic study, we collected pelvic ultrasound images from ten hospitals across China between September 2003, and May 2019. We included consecutive adult patients (aged ≥18 years) with adnexal lesions in ultrasonography and healthy controls and excluded duplicated cases and patients without adnexa or pathological diagnosis. For DCNN model development, patients were assigned to the training dataset (34 488 images of 3755 patients with ovarian cancer, 541 442 images of 101 777 controls). For model validation, patients were assigned to the internal validation dataset (3031 images of 266 patients with ovarian cancer, 5385 images of 602 with benign adnexal lesions), external validation datasets 1 (486 images of 67 with ovarian cancer, 933 images of 268 with benign adnexal lesions), and 2 (1253 images of 166 with ovarian cancer, 5257 images of 723 benign adnexal lesions). Using these datasets, we assessed the diagnostic value of DCNN, compared DCNN with 35 radiologists, and explored whether DCNN could augment the diagnostic accuracy of six radiologists. Pathological diagnosis was the reference standard.

FINDINGS:

For DCNN to detect ovarian cancer, AUC was 0·911 (95% CI 0·886-0·936) in the internal dataset, 0·870 (95% CI 0·822-0·918) in external validation dataset 1, and 0·831 (95% CI 0·793-0·869) in external validation dataset 2. The DCNN model was more accurate than radiologists at detecting ovarian cancer in the internal dataset (88·8% vs 85·7%) and external validation dataset 1 (86·9% vs 81·1%). Accuracy and sensitivity of diagnosis increased more after DCNN-assisted diagnosis than assessment by radiologists alone (87·6% [85·0-90·2] vs 78·3% [72·1-84·5], p<0·0001; 82·7% [78·5-86·9] vs 70·4% [59·1-81·7], p<0·0001). The average accuracy of DCNN-assisted evaluations for six radiologists reached 0·876 and were significantly augmented when they were DCNN-assisted (p<0·05).

INTERPRETATION:

The performance of DCNN-enabled ultrasound exceeded the average diagnostic level of radiologists matched the level of expert ultrasound image readers, and augmented radiologists' accuracy. However, these observations warrant further investigations in prospective studies or randomised clinical trials.

FUNDING:

National Key Basic Research Program of China, National Sci-Tech Support Projects, and National Natural Science Foundation of China.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Deep Learning Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Female / Humans Country/Region as subject: Asia Language: En Journal: Lancet Digit Health Year: 2022 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Deep Learning Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Female / Humans Country/Region as subject: Asia Language: En Journal: Lancet Digit Health Year: 2022 Document type: Article Affiliation country: China
...